$4.65
1.59% day before yesterday
Nasdaq, Dec 27, 10:00 pm CET
ISIN
US74019P1084
Symbol
DTIL
Sector
Industry

Precision BioSciences, Inc. Stock price

$4.65
-2.46 34.60% 1M
-4.77 50.64% 6M
-6.30 57.53% YTD
-6.18 57.08% 1Y
-235.95 98.07% 3Y
-416.85 98.90% 5Y
-475.35 99.03% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.08 1.59%
ISIN
US74019P1084
Symbol
DTIL
Sector
Industry

Key metrics

Market capitalization $18.90m
Enterprise Value $-51.99m
P/E (TTM) P/E ratio 91.00
EV/FCF (TTM) EV/FCF 1.08
EV/Sales (TTM) EV/Sales -0.69
P/S ratio (TTM) P/S ratio 0.25
P/B ratio (TTM) P/B ratio 0.54
Revenue growth (TTM) Revenue growth 43.62%
Revenue (TTM) Revenue $75.10m
EBIT (operating result TTM) EBIT $-16.21m
Free Cash Flow (TTM) Free Cash Flow $-48.31m
Cash position $101.20m
EPS (TTM) EPS $0.05
P/E forward 3.00
P/S forward 0.26
EV/Sales forward negative
Short interest 3.57%
Show more

Is Precision BioSciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Precision BioSciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Precision BioSciences, Inc. forecast:

3x Buy
75%
1x Hold
25%

Analyst Opinions

4 Analysts have issued a Precision BioSciences, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Precision BioSciences, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
75 75
44% 44%
100%
- Direct Costs 5.38 5.38
40% 40%
7%
70 70
61% 61%
93%
- Selling and Administrative Expenses 27 27
6% 6%
36%
- Research and Development Expense 54 54
28% 28%
72%
-11 -11
82% 82%
-14%
- Depreciation and Amortization 5.38 5.38
40% 40%
7%
EBIT (Operating Income) EBIT -16 -16
77% 77%
-22%
Net Profit 8.62 8.62
111% 111%
11%

In millions USD.

Don't miss a Thing! We will send you all news about Precision BioSciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Precision BioSciences, Inc. Stock News

Neutral
Business Wire
11 days ago
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, today announced that it has received Clinical Trial Application (CTA) approval in Hong Kong to study PBGENE-HBV in the ongoing ELIMINATE-B Phase I trial. PBGENE-HBV...
Neutral
Business Wire
about one month ago
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, today announced that it will participate in the following upcoming investor conferences. JonesTrading Virtual Genetic Medicine Day Date: Monday, November 25, 2024 T...
Neutral
Business Wire
about one month ago
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, today will present preclinical data supporting the advancement of PBGENE-HBV into clinical development. The Company will also outline the design of its first-in-hum...
More Precision BioSciences, Inc. News

Company Profile

Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's propriety genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane in January 2006 and is headquartered in Durham, NC.

Head office United States
CEO Michael Amoroso
Employees 109
Founded 2006
Website www.precisionbiosciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today